73 results
8-K
ANIX
Anixa Biosciences Inc
24 Mar 21
Entry into a Material Definitive Agreement
4:28pm
share (“Common Stock”), in an underwritten, firm-commitment public offering pursuant to an effective registration statement on Form S-3 (File No. 333
424B5
ANIX
Anixa Biosciences Inc
24 Mar 21
Prospectus supplement for primary offering
4:15pm
reported sale price of the common stock on the Nasdaq Capital Market was $6.97 per share.
The offering is being underwritten on a firm commitment basis
FWP
do7jq9 5s226d
22 Mar 21
Free writing prospectus
9:53pm
FWP
nz93nn0y2m 4kx
22 Mar 21
Free writing prospectus
5:25pm
424B5
02tkhz
22 Mar 21
Prospectus supplement for primary offering
5:16pm
8-K
EX-3.2
kyiqt6f9
1 Oct 18
Amendments to Articles of Incorporation or Bylaws
4:41pm